Falk Catalyst Research Award Program
Seed funding for innovative translational biomedical research targeting biomarkers, therapeutic targets, or agent development to overcome key barriers and accelerate progress toward clinical application.
Funder: Health Resources in Action
Due Dates (Anticipated): June 2027 (Full application submission deadline, projected)
Funding Amounts: Up to $350,000 total for 1–2 years (inclusive of 10% indirect costs)
Summary: Seed funding for high-risk, high-reward translational biomedical research projects addressing critical therapeutic challenges with potential for clinical impact.
Key Information: Only invited institutions may apply; maximum two applications per institution per cycle.
Description
This program provides seed funding to support innovative, translational biomedical research projects that are poised to overcome major scientific or therapeutic roadblocks and move toward clinical application in the near term. The award is intended for projects that identify disease biomarkers, discover therapeutic targets, or develop agents to disrupt, arrest, or prevent disease processes. Successful Catalyst Award projects lay the groundwork for potential follow-on funding through the Transformational Award.
